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ABSTRACT 
The pig has garnered more and more interest as a model animal to study various conditions in 
humans. The growing success of the pig as an experimental animal model is explained by its 
similarities with humans in terms of anatomy, genetics, immunology, and physiology, by their 
manageable behavior and size, and by the general public acceptance of using pigs for 
experimental purposes. In addition, the immunological toolbox of pigs has grown 
substantially in the last decade. This development led to a boost in the use of pigs as a 
preclinical model for various human infections including sexually transmitted diseases (STIs) 
like Chlamydia trachomatis. In the current review, we discuss the use of animal models for 
biomedical research on the major human STIs. We summarize results obtained in the most 
common animal models and focus on the contributions of the pig model towards the 
understanding of pathogenesis and the host immune response. In addition, we present the 
main features of the porcine model that are particularly relevant for the study of pathogens 
affecting human female and male genital tracts. We also inform on the technological 
advancements in the porcine toolbox to facilitate new discoveries in this biologically 
important animal model. There is a continued need for improvements in animal modeling for 
biomedical research inclusive STI research. With all its advantages and the highly improved 
toolbox, the porcine model can play a crucial role in STI research and open the door to new 
exciting discoveries. 
 
INTRODUCTION 
 
Animal models are crucial for propelling biomedical research inclusive the study of 
infectious diseases. Sexually transmitted infections (STIs) are a major health issue in humans 
and recent global surveys estimate that more than a million STIs are acquired every day, 
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worldwide (Gottlieb and Johnston, 2016; Looker et al., 2015a, 2015b, 2015c; Newman et al., 
2015). In 2012, an estimated 357 million new cases of infections by Chlamydia trachomatis, 
Neisseria gonorrhoeae, Treponema pallidum, and Trichomonas vaginalis, and 19.2 million 
new cases of Herpes simplex virus (HSV) type 2 occurred (Looker et al., 2015b; Newman et 
al., 2015). Researchers are developing vaccines against these STIs and use animal models in 
preclinical trials to: i) optimize vaccine formulation (antigen, adjuvant, delivery vehicle) and 
route of administration (e.g., intramuscular vs. mucosal); ii) determine an effective and safe 
vaccine dosage; and iii) assess the induced immune response to find immune correlates of 
protection and to detect detrimental immune responses. This preclinical development is of 
utmost importance since it maximizes the chances that a vaccine candidate will turn out to be 
protective and safe before it is applied to humans in the subsequent clinical phases. Careful 
selection of an appropriate animal model maximizes the chances that the results obtained in 
preclinical development translate into humans. For some STIs, such as Haemophilus ducreyi 
and genital herpesvirus infections, experimental animal models are well established, while for 
others this development is more challenging. Therefore, researchers are searching for new and 
better animal models. Besides the main animal models mice and non-human primates (NHPs), 
the pig has gained importance as an experimental animal model to study various human 
illnesses.  
Mice are easy to handle with an extensive biological toolbox making them the most 
frequently used animal model in biomedical research. A large number of vaccine candidates 
have been designed and assessed in mice (Bosio et al., 2012; McShane and Williams, 2014). 
While these advantages are useful for the design of vaccine candidates, physiological and 
immunological differences between humans and mice limit their biological relevance for 
preclinical vaccine studies including efficacy and toxicology testing (Bosio et al., 2012; 
McShane and Williams, 2014). Due to the limitations of the mouse model, most vaccine 
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candidates are tested in a second, biologically more relevant animal model before entering the 
clinical phases.  
NHPs are closely related to humans and can provide biological data that is highly 
relevant. The downside of this close relationship to humans is that the use of NHPs for 
biomedical research is controversial due to their high ethical burden. As a result, animal 
experiments in NHPs are heavily regulated, very expensive and the availability of NHPs is a 
pressing concern to biomedical research which represents a significant bottleneck for vaccine 
development. This reality has led to an increasing demand for an affordable, accessible, and 
biologically relevant animal models (Gerdts et al., 2015; Lankau et al., 2014; Meurens et al., 
2012). The pig combines the attributes required for such as model (Box 1) and is gaining 
more and more interest in biomedical research including vaccine development (Gerdts et al., 
2015; Meurens et al., 2012). 
Pigs were first introduced as a large animal model for biomedical research in the 
middle of the 20th century (Gutierrez et al., 2015). The interest in the swine model has since 
then grown due to the many similarities with humans regarding its anatomy, genetic, 
immunology, and physiology (Lossi et al., 2016; Meurens et al., 2012; Swindle et al., 2012). 
Pigs are also widely available, have a manageable size and a behavior that allows for both 
smooth handling and easy experimental interventions. In addition, pigs are accepted as 
experimental animals by the general public, which may not be the case for animals such as 
dogs and NHPs). The biomedical toolbox for pigs has heavily increased during the last decade 
leading to its strongly increased popularity as a model for biomedical research and especially 
for preclinical vaccine studies (Gerdts et al., 2015; Meurens et al., 2012). Over the past ten 
years, many excellent reviews have been published related to the potential and documented 
success of the pig as a biomedical model for conditions in humans (Fairbairn et al., 2011; 
Gerdts et al., 2015; Klymiuk et al., 2016; Meurens et al., 2012; Rogers, 2016; Rogers et al., 
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2008). Various studies that utilized the swine model for the study of human infectious 
diseases with significant contributions and potential new developments were reviewed by 
Meurens et al. (Meurens et al., 2012). One review addressed the use of the swine model in the 
study of the human chlamydiosis (Lorenzen et al., 2015b). With the current review, we 
present the main animal models to study human STIs and we focus on the interest and the 
potential of the swine model to understand and more efficiently reduce the impact of these 
devastating human infections. 
 
EXISTING ANIMAL MODELS FOR INFECTIOUS DISEASES 
The use of experimental animal models to study infectious diseases is necessary to 
improve our understanding of disease pathogenesis and to develop and test preventive and 
therapeutic approaches prior to their use in human clinical trials. A truly effective animal 
model reproduces as many aspects of the human disease under investigation as possible. Two 
main classification systems for animal models exist (Gerdts et al., 2015; Meurens et al., 
2012). The first classification system differentiates (i) spontaneous, (ii) experimentally-
induced or (iii) transgenic models. The second system distinguishes between (i) natural or (ii) 
surrogate models. Logically these two classification systems are not independent and 
spontaneous models are usually naturally occurring while surrogate models are 
experimentally induced or even transgenic in nature. In natural models, animal pathogens 
similar to or even identical (zoonotic pathogens) to the human pathogens are used. In this 
case, animal and human pathogens share a high degree of similarity in their antigenicity, 
genetics, host cell and receptor tropism, and pathogenesis. For surrogate models, the human 
pathogen is administered to a permissive animal. Ideally, the human pathogen should enter the 
animal host via a same route, must replicate at a sufficient level and should target the same 
tissues and organs. However surrogate models can be difficult to establish and usually the 
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disease developed in the model is milder than the disease naturally observed in the human 
host. When a model is selected, different parameters have to be considered to evaluate its 
effectiveness (Denayer et al., 2014; Lorenzen et al., 2015b) including face, predictive and 
target validities. Face validity assesses how well is the biology and symptoms of the disease 
mimicked by the selected model. Predictive validity assesses how well the effects of a 
treatment are mimicked by the chosen model. Target validity assesses how similar the role the 
target system plays in the selected model compared to what is described in humans. 
  
THE PIG AS A MODEL IN THE STUDY OF HUMAN SEXUALLY TRANSMITED 
INFECTIONS 
The porcine model has been used in the study of several human infectious diseases 
(Meurens et al., 2012) and has been subject of many reviews including those focused on using 
large animal models for vaccine development and testing (Gerdts et al., 2015). Very recently, 
the pig was used as surrogate model for emerging Zika virus which increases its potential for 
other diseases that affect the fetus (Darbellay et al., 2017). Pigs have also been used as a 
preclinical models to decipher complex human diseases, and to accelerate the development of 
safe and efficient therapies (Klymiuk et al., 2016; Schomberg et al., 2016). The recent 
development of gene editing tools further increases the potential of large animals, including 
pigs, to model human diseases as presented in some interesting reviews (Rogers, 2016; 
Whitelaw et al., 2016). 
 
THE FEMALE AND MALE PORCINE GENITAL TRACT  
The relevance of the pig as a model for human diseases is based on its similarities in 
regard to anatomy, physiology and immunology. In addition to these aspects, the genital 
microbiome and the influence of the hormonal cycle on the tissue and local immune system 
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increases the complexity of studying STIs in animal models. Lorenzen et al. (Lorenzen et al., 
2015b) provided a comprehensive review on the advantages and disadvantages of the porcine 
female genital tract for studying Chlamydia infections. The following section provides a short 
overview of the most relevant aspects of the porcine female and male genital systems for 
studying human STIs. 
The porcine female genital tract  
Anatomy: One major difference in the gross anatomy of the pig compared to the genital tract 
of women is the bicornual anatomy of the porcine uterus. In women, the genital tract consists 
of the vagina, a short cervix, and a uterus with a single compartment, the uterine body, from 
which the two Fallopian tubes arise. In pigs, the vagina is followed by a long cervix including 
prominent mucosal ridges (cervical pulvini), a common short body and two long horns from 
each of which a Fallopian tube origins (Nickel et al., 1979) (Fig. 1). This difference and 
others have importance in the use of the pig model to study ulcerative and non-ulcerative 
human pathogens targeting the genital tract at various locations such as vagina for 
Trichomonas vaginalis and external genitalia and lower genital tract for ulcerative pathogens 
like Haemophilus ducreyi, Treponema pallidum, Herpesviridae (Herpes simplex virus (HSV) 
types 1 and 2), and Papillomaviridae (Human papillomavirus, HPV). For instance, in the case 
of the infection caused by Chlamydia trachomatis and its ascension into the Fallopian tubes, 
the longer distance between vagina and Fallopian tubes in pigs than in humans may prevent 
the inoculated microorganism from entering the Fallopian tubes. At the microscopic level, the 
most important feature in relation to experimental infections is the location of columnar 
epithelial cells as they are the target cells of several STI pathogens. In women, especially in 
young women, columnar epithelial cells are located in the endocervix, but in pigs the cervical 
canal is covered predominantly by a stratified squamous epithelium in the gilt and sow and 
columnar epithelial cells are present within the uterus (Priedkalns and Leiser, 2006). Hence, 
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to promote a successful infection of columnar epithelial cells, pigs should be administered the 
pathogen directly into the uterine lumen. Due to the presence of the cervical pulvini, 
intrauterine infection via transcervical inoculation should be performed during estrus when 
the cervical canal is permissive and allows catheterization. Synchronization of the porcine 
hormonal cycle via altrogenest (allyl trenbolone 20 mg oral for 18 consecutive days) allows 
for consistent intrauterine inoculations of pigs during estrus – when cervix is opened – and is 
a standard procedure for catheterization during artificial insemination in commercial pig 
production. 
Hormonal cycle: Hormones influence the presence and activity of several immune cell 
subsets and immune modulators. Therefore, it is crucial to understand the differences and 
similarities of the hormonal cycle between pigs and humans. A recent comparative review 
(Lorenzen et al., 2015b) (summarized in Table 1) showed closely related porcine and human 
hormonal cycles with small differences in the one week shorter duration of hormonal cycle in 
pigs and the luteinizing prostaglandin (PG) F2α hormone originating from the uterus in pigs 
and ovaries in women. The epithelium and functional layers of the endometrium show similar 
cyclic changes in women and pigs (Lorenzen et al., 2015b). Interestingly, regarding immune 
cell infiltration in the genital mucosa, there is an influx of neutrophils in the porcine 
endometrium during pro-oestrus and estrus (Hussein et al., 1983; Jiwakanon et al., 2005; 
Kaeoket et al., 2002). While the hormonal cycle is very similar, there is one major difference 
in their physiology. In contrast to women, pigs do not undergo endometrial sloughing 
(menses), which may change the course of infection compared to what occurs in women 
under naturally occurring infections.  
Microflora: Another important difference is the acidic vaginal pH and the flora, which is 
dominated by lactobacilli in women, compared to a neutral pH and a mixed non-lactobacillus 
flora in pigs (Bara et al., 1993; Farage et al., 2010; Mather et al., 1977; Zhou et al., 2004). 
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These differences in flora may not be of significance in experimental studies if inoculation is 
done directly into the uterine lumen.  
The porcine male genital system 
Most studies using pigs as a model of STIs in humans have focused on infections in 
females. However, due to the general similarities between humans and pigs (Lossi et al., 
2016; Swindle et al., 2012), boars can also be interesting as an animal model in the study of 
human STI various aspects (see Table 2). For males, there are species-specific differences that 
one must be aware of, such as differences in the environment, external morphology and 
anatomy of the porcine penis and prepuce. 
While the human penis is characterized as a soft tissue with considerable amounts of 
erectile tissue, the porcine penis is of the fibroelastic type consisting mainly of connective 
tissue with limited amount of erectile tissue. So even erected, the boar penis maintains its 
shape as a hard, thin, tapering ‘stick’. The anterior of the boar penis is twisted counter-
clockwise, while the posterior part is coiled as a sigmoid flexure. Straightening of the flexure 
is responsible for erection, while only a flat plexus of veins at the glans of the penis becomes 
distended (Eurell and Frappier, 2006; König and G, 2009; Lossi et al., 2016; Nickel et al., 
1979; Silverthorn, 2007). The prepuce is much longer than the penis and is covered by hairs at 
the tip. A diverticulum of considerable size is present in the dorsal wall of the prepuce, e.g. in 
an adult Landrace boar it may contain 135 mL of epithelial debris and urine and the opening 
may be passable for two fingers although often closed by mucosal folds (Fig. 2). The prepuce 
is covered by a stratified squamous epithelium (Nickel et al., 1979; Wrobel and Bergman, 
2006). Boars urinate inside the preputial cavity and the external genital tract is located on the 
ventral surface of the abdomen causing a risk for heavy exposure to environmental 
contamination. This may create an environment of the porcine prepuce that is probably very 
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different from the prepuce of men and may make boars unsuited as models of STIs located to 
these structures. 
In man, several sexually transmitted pathogens such as C. trachomatis, Neisseria 
gonorrhoeae, and Mycoplasma genitalium localize to the urethra, which in the membranous 
and penile parts is covered by a stratified or ciliated pseudostratified columnar epithelium 
(Krause, 2005). In the boar, these parts are covered by a transitional epithelium (Wrobel and 
Bergman, 2006). Also, the size of the accessory glands differs, especially because boars have 
extremely large bulbourethral glands (Fig. 2) (Krause, 2005; Nickel et al., 1979; Silverthorn, 
2007). 
 
CURRENT MODELS FOR STIs IN HUMANS AND CONTRIBUTIONS OF THE 
PORCINE MODEL 
The frequent STIs affecting human populations are caused by bacteria, parasites, and 
viruses (CDC 2017, https://www.cdc.gov/std/default.htm). The main bacterial families 
causing STIs are Chlamydiaceae, Mycoplasmataceae, Neisseriaceae, Pasteurellaceae, and 
Spirochaetaceae with C. trachomatis, M. genitalium, N. gonorrhoeae, and T. pallidum as 
their most important species in term of frequency. Their high prevalence coupled with 
increasing levels of antibiotic resistance, especially in case of N. gonorrhoeae and 
Mycoplasma genitalium, has made the quest for currently unavailable effective vaccines 
urgent (Unemo et al., 2017). The most important parasite is T. vaginalis and the major RNA 
and DNA viruses belong to the families Flaviviridae (Hepatitis C virus, HCV), 
Hepadnaviridae (Hepatitis B virus, HBV), Herpesviridae (HSV-1 and HSV-2), 
Papillomaviridae (HPV), and Retroviridae (Human immunodeficiency virus 1 and 2, HIV-1 
and -2).  
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Many animal models provide insights in the pathogenesis of human STIs to facilitate 
the development of vaccines and therapeutics. The following sections address available 
animal models for each of these pathogens including the most common rodent and primate 
models as well as alternative animal models. At the end of each section, we will address how 
swine can contribute as a large animal model for the study of the respective pathogens. 
 
Chlamydia trachomatis 
Chlamydia trachomatis is the most common sexually transmitted bacterium 
worldwide [World Health Organization, 2012, ISBN: 9789241503839]. Infection is often 
asymptomatic. Ascending infections into the Fallopian tubes of women may cause pelvic 
inflammatory disease, tubal infertility, and ectopic pregnancy (Unemo et al., 2017). The 
majority of animal studies have been carried out using mice, guinea pigs and NHPs (for a 
review see (Miyairi et al., 2010)) (Fig. 3). The natural mouse model has been developed with 
C. muridarum, the murine Chlamydia species. Vaginal C. muridarum infections are relatively 
robust and can ascend to the upper genital tract and cause Fallopian tube lesions with 
subsequent complications (de la Maza et al., 1994; Shah et al., 2005). However, there are 
significant differences between C. muridarum and C. trachomatis and these hamper drawing 
parallels with human C. trachomatis infections. Contrary to C. muridarum, which has only 
one serovar, C. trachomatis has 18 substantial allelic variations of the dominant surface 
protein major outer membrane protein (MOMP), while C. muridarum has a single allele 
(Rank and Whittum‐Hudson, 2010). However, the main disadvantage of the mouse model is 
its different sensitivity to IFN-γ. While C. trachomatis can avoid IFN-γ-induced tryptophan 
starvation by expressing a tryptophan synthase, C. muridarum is not able to produce this 
enzyme (Nelson et al., 2005), probably as a consequence of a different effect of IFN-γ on 
human and murine epithelial cells. Contrary to human epithelial cells, murine epithelial cells 
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do not express indoleamine 2,3-dioxygenase following IFN-γ exposure but instead have 
redundant mechanisms using nitric oxide synthase and others (Ramsey et al., 1998). Mice can 
be infected with C. muridarum as well as C. trachomatis, although infections with the later 
are usually mild and mice lacking functional T-cells are able to clear C. trachomatis 
infections (Tuffrey et al., 1982). Coers et al. generated Immunity Related GTPase (IRG) 
knockout mice in order to overcome this limitation. These knockout mice developed a 
transient high bacterial burden upon intrauterine inoculation with the C. trachomatis serovar 
L2. Clearance of this infection was at least partly driven by CD4+ T cells (Coers et al., 2011). 
Chlamydia trachomatis infections do not ascend to the Fallopian tubes in mice, a key 
aspect for studying chlamydial pathogenesis (Farris and Morrison, 2011). Therefore, sequelae 
of C. trachomatis infection are induced in mice by direct inoculation of the upper genital tract. 
This inoculation route has one disadvantage in modeling natural human infections: “During 
natural human infection, the time required for ascension of the bacterium to the Fallopian 
tubes may allow for homing of protective memory T-cells, leading to a decrease in the 
infectious inoculum and consequent damaging inflammation at this vulnerable tissue site” as 
stated by Darville and Hiltke (Darville and Hiltke, 2010). Furthermore, other differences 
could hamper the translation of findings from mice to humans, such as the hormonal treatment 
to enhance infection, different size of the hosts limiting the collect of samples, and the higher 
vaginal pH of 6.6 in mice compared with 3.5-5 in women.  
Guinea pigs are another natural model frequently used to study chlamydial infections, 
generally with C. caviae as the infective agent. Intravaginal C. caviae inoculation of guinea 
pigs leads to ascension through self-limiting infections which appear to resemble C. 
trachomatis infections in women (Rank et al., 1982). In a recent study, de Jonge et al. 
introduced an alternative guinea pig model using C. trachomatis, which also showed 
indications of ascending infections (de Jonge et al., 2011). However, guinea pig models have 
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drawbacks such as a smaller size than humans. Another issue is the limited molecular toolbox 
in guinea pigs which has likely contributed to the low number of studies on chlamydial genital 
tract infection, although studies on C. caviae genital infections of guinea pigs date back to 
1972 (Mount et al., 1972).  
NHPs are close relatives to humans and have also been used as animal models for C. 
trachomatis infection. Intracervical inoculation with human C. trachomatis serovars can result 
in long-term (up to 15 weeks) infections in pig-tailed macaques (Macaca nemestrina) 
(Wolner-Hanssen et al., 1991) and repeated inoculations can result in the ascension of 
infection to the Fallopian tubes (Patton, 1985). However, NHP models suffer from the 
previously mentioned ethical problems and are expensive (Meurens et al., 2012). 
The pig is the natural host to C. suis, a very prevalent pathogen with a high similarity 
to C. trachomatis (Schautteet and Vanrompay, 2011). Genital C. suis infections can lead to 
similar pathological changes and disease outcomes as C. trachomatis infections and have been 
associated with reproductive disorders as reduced conception rates and inferior semen quality. 
Importantly, recent studies demonstrate a zoonotic potential for C. suis (Dean et al., 2013; De 
Puysseleyr et al., 2017). Due to the close relationship between C. trachomatis and C. suis and 
the similar disease outcomes in swine, researchers have started to use the pig as a large animal 
model to study C. trachomatis infections and for developing and testing C. trachomatis 
vaccines using either conventional pigs or minipigs (Bøje et al., 2016; Käser et al., 2017; 
Lorenzen et al., 2017; Schautteet et al., 2012, 2011a). 
The minipig model: Several studies using vaginal inoculation with the C. trachomatis 
SvD/UW-3/Cx strain (ATCC® VR-885™) in sexually mature female Göttingen minipigs 
during estrus were developed and characterized as a porcine model of genital chlamydiosis in 
women for use in vaccine studies (Bøje et al., 2016; Lorenzen et al., 2017).  
Chlamydia trachomatis infection via deep vaginal inoculation: 
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A self-limiting infection was induced following deep vaginal inoculation of 1.8 × 109 
inclusion forming units (IFUs). The minipigs were followed for up to seven days during 
which the infection declined with only a few samples being slightly positive by quantitative 
polymerase chain reaction (qPCR) for chlamydial 16S rRNA on day 7. C. trachomatis was 
found by qPCR in both the uterus and Fallopian tubes of individual minipigs, but the infection 
was associated with only a mild inflammatory response limited to the cervico-vaginal mucosa. 
As determined by immunohistochemistry (IHC), replication was limited and confined to the 
cervico-vaginal epithelium, where it was associated with cyclooxygenase-2 and interleukin-8 
expression (Erneholm et al., 2016). Similar rapid clearance was observed in non-vaccinated 
control minipigs inoculated with either 3.9 × 109 IFUs (Bøje et al., 2016) or 5 × 109 IFUs 
(Lorenzen et al., 2015a) as part of vaccination studies. Significant levels of infection were not 
found beyond 3 days after inoculation in neither of the studies and C. trachomatis was not 
found in the uterus and the Fallopian tubes at necropsy performed 15 days after challenge 
(Lorenzen et al., 2015a).  
Chlamydia trachomatis infection via intrauterine and transcervical inoculation: 
In an attempt to establish a longer lasting infection by inoculating the bacteria at a site where 
columnar epithelial cells were present, Lorenzen et al. (Lorenzen et al., 2017) performed 
intrauterine inoculation during laparotomy using a dose of either 1 x105 or 1 x 108 IFUs as 
well as a transcervical challenge using a dose of 1 x 109 IFUs. The rationale behind 
inoculation directly into the uterine lumen was the absence of columnar epithelial cells in the 
vagina and cervix of minipigs and the longer cervical canal with mucosal folds, which may 
have prevented sufficient numbers of bacteria to have reached the uterine mucosa in the 
previous studies (Bøje et al., 2016; Erneholm et al., 2016; Lorenzen et al., 2015a). The 
transcervical challenge during estrus induced an infection in all (8/8) inoculated animals up to 
seven days post inoculation. A dose of 1 x 105 IFUs using laparotomic intrauterine inoculation 
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proved insufficient to establish an infection, but the high doses established an infection with a 
higher bacterial load than following vaginal inoculation (≈ 2 log units) and an infection that 
lasted for up to seven days. Furthermore, the infection was associated with significant acute 
uterine suppurative inflammation and Chlamydia replication in columnar epithelial cells was 
shown by IHC in some minipigs. Intrauterine inoculation via laparotomy during estrus was 
short (up to 5 days) and self-curing but during diestrus this infection induced a long-term 
infection until the end of the study (10 days). This difference can be explained by the higher 
activity of the uterine mucosal innate immune system of pigs during estrus (Erneholm et al., 
2016; Lorenzen et al., 2015b).  
Conclusions: 
Based on these findings, it is recommended that minipigs should be inoculated either 
transcervically during estrus, when cervix is opened, with 1 x 109 IFUs or directly into the 
uterine lumen via laparotomy during diestrus with 1 x 108 IFUs to facilitate establishment of a 
longer lasting infection. However, laparotomy is complicated by the anatomy and constriction 
of the cervical canal during diestrus.  
The minipig model needs to be further developed, especially to mimic long-term 
infections and development of chronic lesions in the Fallopian tubes as seen in cases of 
chronic genital chlamydiosis in women. 
The conventional pig model: Conventional pigs have been used for studying C. trachomatis 
infections since 2005 (Schautteet et al., 2012, 2011a, 2011b; Vanrompay et al., 2005).  
Infection and basic immune response analysis upon C. trachomatis vaccination and challenge: 
Based on studies on pigs inoculated intravaginally with 108 IFUs C. trachomatis strain E Bour 
and 468 it was concluded that both strains ascended to the Fallopian tubes, induced pathology, 
and triggered a humoral immune response (Vanrompay et al., 2005). In 2011, two C. 
trachomatis trials in pigs were performed to test two recombinant protein vaccines and a 
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MOMP-based DNA vaccine. Upon intravaginal challenge with 108 IFUs C. trachomatis E 
Bour, Schautteet et al. (Schautteet et al., 2011a, 2011b) reported less severe macroscopic 
lesions and decreased C. trachomatis replication and vaginal excretion in the group 
vaccinated by the MOMP-based DNA vaccine. The recombinant protein vaccine using PmpG 
as antigen also induced partial protection to C. trachomatis infection based on scoring of 
lesions. Protection did not correlate with a humoral immune response and T-cell immune 
response was not investigated (Schautteet et al., 2011a, 2011b). In 2012, the same group 
performed another vaccination trial comparing mucosal vs. intradermal DNA immunization. 
In comparison to intradermal vaccination, the mucosal vaccination route induced globally a 
stronger immune response but still only a partial protection against C. trachomatis challenge. 
Higher serum IgA levels and T-cell priming correlated with protection, although the authors 
did not test for C. trachomatis-specific T-cells since in vitro restimulation was performed 
using Concanavalin A instead of chlamydial antigens (Schautteet et al., 2012).  
Deciphering the T-cell immune response to C. trachomatis and C. suis infection: 
The induction of Chlamydia-specific T-cells by C. suis and C. trachomatis was focus of a 
recent study by Käser et al. (Käser et al., 2017). In that study, conventional pigs were infected 
transcervically with 108 IFUs C. suis (strain S45) or C. trachomatis (strain E Bour). The 
authors followed the infection for 21 days and analyzed chlamydial titers in vaginal swabs 
and genital tissue at necropsy. The induction of the humoral immune response was analyzed 
by determining neutralizing antibody levels in blood, and the activation and cytokine 
production of different T-cell subsets in blood (time-course) and the draining lymph nodes (at 
necropsy) using polychromatic (multi-color) flow cytometry (pFCM). C. suis and C. 
trachomatis were detectable in vaginal swabs until 21 days and 7 days post infection, 
respectively. Analyzing chlamydial infection in the upper genital tract at necropsy (uterine 
horn flushes and tissue with gross lesions) showed that the infection was still ongoing in this 
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location in 3/5 (C. suis) and 4/5 (C. trachomatis) infected animals until 21 days post infection. 
While only infection with C. suis induced neutralizing antibodies, both Chlamydia species 
induced a CD4+ T-cell immune response in most animals with IFN-ɣ single-, and IFN-γ/TNF-
α double-producing CD4+ T-cells as main responders (Käser et al., 2017). The detected IFN-γ 
single-, and IFN-γ/TNF-α double-producing CD4+ T-cells have been reported previously to be 
the best correlates of protection against C. muridarum infection (Yu et al., 2011). 
Conclusions: 
The conventional pig model requires further establishment to provide a more 
consistent and resilient infection with C. trachomatis to induce a stronger immune response. 
Nevertheless, the performed studies demonstrate the potential of the pig to study C. 
trachomatis infections inclusive of vaccination studies. The current improvements in the 
porcine immunological toolbox provide a sensitive pathogen detection system combined with 
an in-depth analysis of the induced immune response including neutralizing antibody levels 
and multifunctional T-cells. 
 
Haemophilus ducreyi 
Haemophilus ducreyi is the etiologic agent of chancroid, a sexually human transmitted 
disease characterized by painful sores on the genitalia consecutive to the development of 
ulcerating cutaneous lesions. The disease is a lot less frequent today than it was before and far 
less prevalent than other diseases presented in this review (González-Beiras et al., 2016). 
However, because the pig model has been considerably used to study H. ducreyi (Afonina et 
al., 2006; Fulcher et al., 2006; Hobbs et al., 1995), it has been chosen to present it here too. 
Indeed, studies have shown evidences that the histopathology of the lesions in the ear skin pig 
model closely resembles that of human chancroid (Hobbs et al., 1995) and that the swine 
immunology and skin structure closely resemble their human counterparts (Summerfield et 
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al., 2015b). The temperature-dependent rabbit model has also been used to obtain data on 
associated virulence factors and immuno-pathogenesis of chancroid H. ducreyi infections 
(Desjardins et al., 1996, 1995). Studies using this model demonstrated that infected whole-
cells, crude outer membrane protein mixtures or purified vaccine proteins could induce an 
immune protection against H. ducreyi infections. However, the antibodies produced did not 
show bactericidal or opsonophagocytic capacities (Desjardins et al., 1996, 1995). Finally, 
some studies were also performed using NHPs (i.e., Macaca mulatta) (Sturm, 1997; Totten et 
al., 1994). These NHPs had the advantage of allowing the assessment of some strains which 
were not virulent in the rabbit model even if pathogenic for humans (Sturm, 1997).  
Most porcine data in the study of H. ducreyi pathogenesis were generated using the 
surrogate ear skin swine model developed in crossbred (Yorkshire, Landrace, Hampshire, and 
Duroc Cross) or purebred (Landrace) conventionally reared swine (Hobbs et al., 1995). This 
swine model established which immune cell types were involved in H. ducreyi infection 
(Hobbs et al., 1995). Analysis by Western blots of H. ducreyi proteins presented in swine 
serum after 2 weeks of inoculation demonstrated a response characterized by increased 
concentrations of IgG antibodies targeting H. ducreyi antigens (Hobbs et al., 1995). Other 
studies tried to identify the mechanism of entry, colonization steps and pathogenesis, and to 
define factors present into immune serum that conferred protection against H. ducreyi. These 
studies demonstrated that H. ducreyi infection requires two TonB-dependent receptors - the 
hemoglobin receptor (HgbA) and a receptor for free heme (TdhA) - and that the NcaA outer 
membrane protein is required for collagen binding (Afonina et al., 2006; Fulcher et al., 2006). 
Anti-HgbA IgG was able to block hemoglobin binding to the HgbA receptor showing the 
importance of HgbA in the development of vaccine candidates against chancroid (Afonina et 
al., 2006; Fulcher et al., 2006). Based on these studies, the swine model appears interesting to 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
19 
 
answer questions related to H. ducreyi pathogenesis, to perform therapeutic trials, and to 
develop vaccine candidates. 
 
Mycoplasma genitalium 
Mycoplasma genitalium is a common STI agent causing urethritis in both men and 
women, and cervicitis and pelvic inflammation in women. This emerging bacterium was first 
described in the 1980s in men with non-gonococcal and non-chlamydial urethritis (Tully et 
al., 1981). Since then, others studies have confirmed the involvement of M. genitalium in 10-
35% of human reproductive tract non-gonococcal and non-chlamydial inflammatory diseases 
including urethritis in men, and cervicitis, pelvic inflammatory disease, and infertility in 
women (Jensen et al., 2016). Its prevalence is increasing and rivaling that of C. trachomatis. 
Furthermore, it is resistant to antibiotics and treatment options are becoming more limited 
(Manhart, 2017). Animal studies are needed to comprehensively study the pathogenesis of M. 
genitalium, particularly its contribution to ascending genital tract infections of women 
(Wiesenfeld and Manhart, 2017). To date, few studies have been conducted to establish an 
animal model to obtain better knowledge of the M. genitalium pathogenesis. The literature 
includes mainly studies using several NHP infection surrogate models including chimpanzees 
(Pan troglodytes – not allowed anymore) and pig-tailed macaques to investigate pathogenesis 
and host responses (Taylor-Robinson et al., 1987; Wood et al., 2017). 
NHP studies: M. genitalium infection established classically by the urogenital route 
induces clinical manifestations in pig-tailed macaques similar to the ones observed in humans 
with a large number of polymorphonuclear leukocytes infiltrating the genital tract (Wood et 
al., 2017). In addition a specific serum antibody response could be demonstrated further 
proving host susceptibility (Wood et al., 2017). However, not all NHPs are susceptible to M. 
genitalium infection, including rhesus monkeys (Macaca mulatta) whose vaginal mucosa 
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does not allow bacterium colonization, thereby preventing ascending infection (Taylor-
Robinson et al., 1987).  
Rodent studies: Mice and hamsters are also naturally resistant to infection. A group of 
researchers has developed a female mouse model in which mice are treated with estradiol or 
progesterone at 7 days and at 1 day prior to M. genitalium type G37 or M2300 strain 
inoculations (McGowin et al., 2010). This model has been able to demonstrate a causal 
association of M. genitalium with reproductive disease by upper genital tract infection 
following vaginal exposure (McGowin et al., 2010). 
Swine model: No swine model has been described for the study of M. genitalium and 
since this bacterium is very restricted to a small number of primates, the opportunity to 
develop a new model in the pig seem limited and would need further assessment. 
 
Neisseria gonorrhoeae 
Neisseria gonorrhoeae is the second most prevalent bacterial STI globally causing the 
disease gonorrhea (Unemo et al., 2017). It is an exclusively human pathogen which causes 
considerable morbidity and occasional mortality through untreated ectopic pregnancy 
worldwide. Up to 50% of cases may be asymptomatic and females are disproportionately 
affected because of the consequences of untreated or undetected disease (Hill et al., 2016) 
including pelvic pain caused by ascending genital tract infections, pelvic inflammatory 
disease, occlusion of the Fallopian tubes due to inflammation and ectopic pregnancy. There is 
no vaccine for gonorrhea but the need has become urgent as antibiotic resistance has become 
widespread and threatening the ability to cure the infection. The organism has been studied in 
various animal models including NHPs, rabbits, guinea pigs, mice, and chicken embryos 
(Arko, 1989). Historically, the main issue with these models was the presence of several host 
restrictions. In mice, the use of estradiol reduced this limitation by an unknown mechanism 
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which has led to their use as a surrogate host for N. gonorrhoeae (Jerse et al., 2011). 
Estradiol-treated mice are now the most common animal model used for studying gonococcal 
infections. Nevertheless, important differences exist between the genital tract of women and 
female mice thereby limiting the use of the mouse as an N. gonorrhoeae animal model. The 
vaginal pH in female mice is higher than the human vaginal pH, mostly due to differences in 
resident microbial populations and mice do not experience menstrual bleeding, which would 
bring hemoglobin, proteases, and various serum factors into the lumen of the reproductive 
tract (Jerse et al., 2011) (see Table 1).  
Several host restrictions have been described for N. gonorrheae and complicate the 
establishment of animal models (Jerse et al., 2011; Ngampasutadol et al., 2008). These host 
restrictions include, for instance, lack of human CD46 counterpart in some species, which can 
serve as a N. gonorrhoeae pilus receptor (Jerse et al., 2011; Kallstrom et al., 1997; Källström 
et al., 2001), human CR3 integrin counterpart (Edwards et al., 2002), and human 
carcinoembryonic antigen cellular adherence molecules (CEACAMs) 1, 5, and 6 counterparts 
to which the phase variable opacity (Opa) proteins bind and CEACAM3, through which Opa-
mediated uptake by neutrophils occurs without opsonization (Jerse et al., 2011; Sadarangani 
et al., 2011). A better understanding of host restrictions through the use of the transgenic mice 
such as CEACAM1 transgenic mice (Gu et al., 2010) and the identification of the mechanism 
behind the estradiol treatment making female susceptible to the infection are needed. 
Although N. gonorrhoeae is an obligate human pathogen, there are species of the 
Neisseriaceae that are able to infect pigs. A pig-specific strain was recognized when five 
strains of an unusual Gram-negative, coccobacillus-shaped bacterium were isolated from the 
lung and heart of pigs with pneumonia and pericarditis and subjected to comparative 16S 
rRNA gene sequencing (Vela et al., 2005). Results showed that the strains were 
phylogenetically highly related to each other and were related to the family Neisseriaceae 
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(Vela et al., 2005). On the basis of both phenotypic and phylogenetic evidence, the isolates 
from pigs were classified as a novel genus and species within the family Neisseriaceae, 
named Uruburuella suis. Despite being identified in 2005, no studies have been published 
indicating how widespread U. suis is in the pig population around the world, how it is 
transmitted, whether it causes infection and whether it acts as an STI in pigs or other species. 
Such studies might assist in understanding N. gonorrhoeae transmission and infection 
dynamics in humans. 
Limited research has been performed to establish that porcine cells can be infected 
with N. gonorrhoeae. Using ex vivo porcine vaginal mucosa (PVM) as a tissue model 
Breshears et al. (Breshears et al., 2015) determined that human clinical isolates of N. 
gonorrhoeae could colonize these cells and form biofilms. The PVM mucosal explants were 
inoculated with ~104 CFUs/explant of N. gonorrhoeae which then grew to ~ 1.1 x 
107 CFUs/explant (~4.2 x 107 CFUs/mL) with peak growth at 24 – 48 h. N. gonorrhoeae grew 
well under aerobic conditions but they grew poorly under anaerobic conditions and growth 
was optimal on the PVM when the underlying media was at pH 5.5 – 6.5. PVM colonized 
with N. gonorrhoeae exhibited robust biofilm development within 24 h and showed a thick 
biofilm covering the majority of the explant after 48 h. Epithelial cells visible between 
patches of N. gonorrhoeae biofilm were alive (Breshears et al., 2015) which indicates that at 
least ex vivo, N. gonorrhoeae could colonize, grow and form biofilms on pig vaginal mucosa. 
Researchers from the Wilson and Dillon laboratories have isolated primary porcine genital 
tract epithelial cells to establish whether they can be infected by N. gonorrhoeae (Wilson and 
Dillon, unpublished data). N. gonorrhoeas FA1090 adhered to primary pig genital tract 
epithelial cells after 2 h (Wilson and Dillon, unpublished data) and further research is being 
performed to establish invasion and growth of the bacteria. Preliminary data also showed that 
the porcine cervical and uterine mucosa have abundant expression of the CR3 (CD11b/CD18) 
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gene but that the primary genital tract epithelial cells have negligible expression for this 
receptor (Edwards et al., 2001). We are currently investigating whether culturing the primary 
cells with estrogen impacts CR3 expression.  
 
Treponema pallidum 
Syphilis, a bacterial STI caused by T. pallidum subspecies pallidum, results in the 
establishment of a persistent and recurrent infection and is implicated in substantial morbidity 
and mortality (Hook, 2017). The infection occurs globally in human populations and accounts 
for more than 5 million new cases every year (Hook, 2017). The natural course of untreated 
syphilis progresses through successive stages including primary, secondary, latent, and 
tertiary manifestations. The primary manifestations are characterized by an ulcerative lesion 
at the port of entry. In men, a painless ulceration (chancre) is most often seen on the distal 
penis whereas in women, lesions in the vagina, cervix, rectum, perirectally, or in the mouth 
are most prevalent (Hook, 2017). Humans are the only natural host for T. pallidum subspecies 
pallidum, which restricts the use of animal models. Furthermore, it is slowly growing 
bacterium that cannot be cultured. An in vitro model with the invasion of tissues by 
pathogenic T. pallidum has been developed but is not used anymore (Riviere et al., 1989). To 
date, rabbits are the only mammal to develop naturally-occurring syphilis caused by T. 
paraluis-cuniculi, a bacterium closely related to T. pallidum subspecies pallidum with 
genomic sequence similarity near 99%, antigenic cross reactivity and similar symptoms (Peng 
et al., 2015; Strouhal et al., 2007). Consequently, the natural rabbit model has been used to 
investigate pathogenesis and immunity of human syphilis or to develop therapeutic 
approaches (Morgan et al., 2002; Peng et al., 2015; Tantalo et al., 2005). The guinea pig 
model has also been used to study the pathogenesis and the development of the adaptive 
immune response to T. pallidum (Wicher et al., 1999). Other animal models such as guinea 
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baboons (Papio papio) have also been reported to be sensitive to T. pallidum subspecies 
pertenue with clinical manifestations ranging from being asymptomatic to severe skin and 
mucous membranes ulcerations (Harper and Knauf, 2013). This subspecies is known to cause 
yaws in humans. The infection has a chronic course and is transmitted by direct contact but 
yaws can be considered as a STI. Yaws is the most frequent of the tropical endemic 
treponematoses. Infection by T. pallidum subspecies pertenue causes a skin infection, which 
can then spread and produce lesions in the deeper structures, in particular bone, by contiguity. 
Yaws is not a deadly disease, but it is painful, disfiguring, and those who suffer from it are 
socially stigmatized. Today, there is no absolute animal model to directly study the 
pathogenesis and the immune response to human syphilis or to test therapeutic approaches or 
vaccine candidates against this bacterium. 
For this bacterium, the swine model has a poor potential so far. Treponema spp. are 
very adapted to their specific host and, in the pig, Treponema pedis are not associated with 
genital lesions but rather ear necrosis and shoulder ulcers (Svartström et al., 2013). 
 
Trichomonas vaginalis 
 Also known as urogenital trichomoniasis, the anaerobic, flagellated protozoan parasite 
Trichomonas vaginalis causes non ulcerative vaginitis in women and urethritis in men 
(Kissinger, 2015). T. vaginalis infection is the most prevalent non-viral STI in the world and 
there are more cases of T. vaginalis infections than C. trachomatis, N. gonorrhoeae, and T. 
pallidum infections combined (Gottlieb and Johnston, 2016; Kissinger, 2015; Newman et al., 
2015; Satterwhite et al., 2013). Most studies about trichomoniasis animal models have been 
carried out using pig-tailed macaques and mice (Abraham et al., 1996; Corbeil, 1995; 
Meysick and Garber, 1992; Nogal-Ruiz et al., 2005, 2003; Nogal Ruiz et al., 1997; Smith and 
Garber, 2015). In the last years murine models were mainly used to improve our knowledge 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
25 
 
of host-parasite relationships, mechanisms of pathogenesis, parasite virulence factors, and 
parasite-induced immune response. More recently the natural bovine animal model –based on 
T. foetus, a trichomonas species very similar to T. vaginalis naturally infecting bovine– has 
been reviewed showing some interest in the study of parasite-induced immune response 
(Chapwanya et al., 2016). Even more recently, several teams have used non-human primate 
models (pig-tailed macaques) to assess new preventive treatments against T. vaginalis 
infection and to gain insights in the understanding of HIV and C. trachomatis co-infections 
(Henning et al., 2014; Makarova et al., 2017; Radzio et al., 2016). Interestingly, reports 
demonstrated that a single T. vaginalis inoculation could result in persistent infection in the 
pig-tailed macaque. In 2015, for the first time, experiments were carried out using PVM 
(surrogate model) to evaluate non-conventional treatments against T. vaginalis infection 
demonstrating an interest for the pig model in the study of this important STI (Pradines et al., 
2015). 
 
Hepatitis C virus 
For a long time, research on human HCV has been hampered by the lack of an 
appropriate animal model. Most research has been carried out in the chimpanzee (Pan 
troglodytes) model, with important limitations in terms of ethics, small sample sizes, high 
costs, and genetic heterogeneity (Mesalam et al., 2016), and in the horse model with similar 
limitations too (Ramsay et al., 2015). Recent models involving chimeric mice with humanized 
livers and rodent species such as the deer mouse (Peromyscus maniculatus) have improved 
the situation (Mesalam et al., 2016; Vandegrift et al., 2017). The deer mouse natural model is 
particularly attractive with the recent discovery of a HCV homolog in this species (Kapoor et 
al., 2013). These mice are available commercially, develop a spontaneous disease very similar 
to HCV hepatitis and can serve as natural model to inform about various aspects of this 
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human disease (Vandegrift et al., 2017). There is no pig model to study human HCV 
infection. 
 
Hepatitis B virus 
Developing animal models for the study of viral hepatitis has always been challenging. 
Besides humans only chimpanzees have so far been shown to be natural hosts of HBV 
(Protzer, 2017). Other mammals such as small shrew mice (Soricidae sp.) are also permissive 
to the virus but at a very low level, which restricts their use as experimental models (Allweiss 
and Dandri, 2016). Surrogate models have also been developed in Pekin ducks and 
woodchucks (groundhog [Marmota monax]). Unfortunately, the disease pathogenesis in these 
species is drastically different limiting their use (Allweiss and Dandri, 2016). However, in 
vitro models are improving and very recently macaque and pig hepatocytes susceptible to 
HBV were reported, opening the door to the development of new animal models (Lempp et 
al., 2017). Lempp et al. (Lempp et al., 2017) showed that in macaque and pig hepatocytes, the 
sodium taurocholate cotransporting polypetide (NTCP) is the key host factor limiting HBV 
infection. Complementation of dog, mouse and rat hepatocytes with human NTCP made them 
susceptible to hepatitis D virus (HDV), but not to HBV, demonstrating the requirement of 
supplementary HBV-specific factors while macaque and pig hepatocytes became fully 
susceptible to HBV with the same modification (Protzer, 2017). This observation in macaque 
and pig paves the way to the development of new immunocompetent infection models 
supporting the full HBV life cycle (Protzer, 2017). 
The recent finding that porcine hepatocytes expressing NTCP became susceptible to 
HBV replication has opened the door to the development of a surrogate porcine model to 
study this important human pathogen (Lempp et al., 2017). So far, obtained in vitro results are 
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promising and further research is required to fully appreciate the potential of the pig as a 
relevant surrogate model in the study of HBV pathogenesis and host/pathogen interactions. 
 
Herpesviruses 1 and 2 
Nine herpesviruses are described in humans (Pellett and Roizman, 2013) with the best 
known of these double-stranded DNA viruses being HSV-1 and its “cousin” the HSV-2 
(Roizman et al., 2013). HSV-1 is mainly transmitted by oral contact to cause disease in or 
around the mouth while HSV-2 is almost exclusively sexually transmitted, inducing ulcerative 
lesions in the lower genital tract and sometimes cervix (Roizman et al., 2013). It is estimated 
that 417 million people aged 14–49 were infected worldwide in 2012 (Looker et al., 2015c). 
However, HSV-1 can also be transmitted to the genital tract through oro-genital contacts and 
accounts for half of new cases in developed countries (Aravantinou et al., 2017). Guinea pig 
and mouse surrogate models have been used both for HSV-1 and HSV-2 mucosal infections 
(Kollias et al., 2015; Parr and Parr, 2003). In guinea pigs, continual recurrences of the lesions 
were observed but the isolation of HSV from the lesions was sometimes challenging (Kollias 
et al., 2015). A cotton rat (Sigmodon hispidus) model has also been shown to develop 
recurrent lesions (Yim et al., 2005). However, this model is still less characterized than the 
guinea pig model. More recently, an experimental surrogate model has also been developed in 
rhesus macaques (Macaca mulatta) for the study of genital HSV-1 infection (Aravantinou et 
al., 2017). 
The main herpesvirus infecting pigs is Suid herpesvirus 1 (SuHV-1), an infection 
causing Aujeszky’s disease (Pellett and Roizman, 2013). This virus is a member of the genus 
Varicellovirus in the Herpesviridae family as HSV-1 and HSV-2. In piglets, Aujeszky’s 
disease starts as an acute inflammation of the upper respiratory tract and then progresses to 
fatal encephalomyelitis (Wittmann and Rziha, 1989). Some pigs can also develop vesicular 
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lesions around the mouth, nose, and conjunctiva very similar to symptoms observed with 
HSV-1 infection in humans. Growers/finishers and adult pigs may only experience respiratory 
disease as natural transmission of the virus occurs through the oronasal route (Wittmann and 
Rziha, 1989). Moreover, the virus is also transmitted by mating and embryo-transfer and can 
impact reproduction (Wittmann and Rziha, 1989). However, genital lesions are usually not 
described and further research would be required to fully appreciate the potential of SuHV-1 
as a model to study the pathogenesis of genital HSV infection and the host immune response 
it can induce. 
 
Human papillomavirus 
Human papillomaviruses, potentially causing genital warts and even -if not treated- 
cervical cancer, have been intensively studied and currently more than 120 different HPV 
types have been reported (Bernard et al., 2010; Howley et al., 2013). The species-specific 
nature of papillomaviruses has prevented adaptation of authentic HPV infections to 
experimental animal models. However, significant discoveries in the understanding of 
papillomaviruses pathogenesis have been carried out using cattle, dog, NHP, and rabbit 
(Sylvilagus floridanus and Oryctolagus cuniculus) natural models (Christensen et al., 2017). 
More recently new models have been developed in mice and multi-mammate rats 
(Christensen et al., 2017). Anogenital lesions including neoplasia are described in humans and 
are associated predominantly to HPV-16 and HPV-18 (Howley et al., 2013). Amongst animal 
papillomaviruses, Rhesus papillomavirus (RhPV) and potentially baboon (Papio hamadryas 
anubis) papillomaviruses can be sexually transmitted between monkeys and can be associated 
to the development of cervical neoplasia (Bergin et al., 2013; Wood et al., 2007). HPV-16 
and RhPV are very similar and macaque can make a good natural model for the study of HPV 
pathogenesis and for the development of preventive and therapeutic approaches. 
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Only one report has been published regarding porcine papillomaviruses (Stevens et al., 
2008). These porcine viruses are not fully characterized yet and their potential pathogenicity 
needs to be determined. Thus, it is too early to appreciate the potential interest of the swine 
model for human papillomaviruses. 
 
Human immunodeficiency virus 1 and 2 
Infections with HIV-1 and -2 cause the Acquired Immune Deficiency Syndrome 
(AIDS). This disease continues to be a major public health issue despite continuous progress 
in its management (Goff, 2013; Kuritzkes and Koup, 2013). The infection is characterized by 
a slow and progressive destruction of CD4+ T-cells leading finally to fatal 
immunosuppression. Even if the last years have seen great progress in the understanding of 
HIV infection and AIDS, there are still challenges, particularly the development of vaccines, 
new therapeutic approaches and resolution of HIV-induced inflammation. A limitation in HIV 
research is the lack of a totally suitable animal model. Natural models such as the rhesus 
macaques being infected by the Simian immunodeficiency virus (SIV) and humanized mice 
develop a disease that is similar to AIDS in humans (Evans and Silvestri, 2013; Garcia-Tellez 
et al., 2016; Victor Garcia, 2016). So far rhesus macaques/SIV model is the best model as it 
meets the conditions required to constitute a reliable animal model for a human infectious 
disease (Garcia-Tellez et al., 2016): (i) The pathogen causing a disease in the model should 
cause a disease similar to the disease caused by the human pathogen in humans; (ii) The 
course of the disease in the animals should resemble that in humans; (iii) Cells, tissues, and 
organs involved in the pathogenesis should be similar in the model and humans; (iv) Immune 
response to infection in the model should be similar to its counterpart in humans. All these 
conditions are not fulfilled in other animal models, i.e. Feline immunodeficiency virus in the 
cat and HIV in humanized mice (Garcia-Tellez et al., 2016). Thus, currently, non-human 
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primates and humanized mice are the only animals able to model correctly the pathogenesis of 
HIV (Garcia-Tellez et al., 2016; Victor Garcia, 2016). 
There is no naturally occurring Retroviridae similar to HIV in the pig preventing the 
development of experimental model in this species to study HIV. The only virus with some 
similarities in terms of pathogenicity to HIV in the pig would be the Porcine reproductive and 
respiratory syndrome virus (PRRSV), a member of the Arteriviridae family (Lunney et al., 
2016). However, there are many differences between the two viruses limiting the interest of 
PRRSV as a natural model to study HIV. 
 
DEVELOPMENTS IN THE PORCINE TOOLBOX – STANDARDS AND NEW 
POSSIBILITIES 
 
The usefulness of an animal model for biomedical research depends highly on the 
availability of the appropriate tools to analyze the host-pathogen interactions. Due to the 
smaller market for biomedical research in pigs, it is understandable that the porcine toolbox is 
still not comparable to mice. Nevertheless, there were major developments in the porcine 
biomedical toolbox during the past ten years leading to major improvements in analyzing the 
host-pathogen interactions in pigs and the use of the pig as an animal model for studying 
human diseases including STIs. The following section provides an overview on the current 
standards and new developments for the porcine toolbox and their implications for studying 
human STIs. 
 
The porcine genome 
The Swine Genome Sequencing Consortium initiated the sequencing of the porcine 
genome in 2003 (Schook et al., 2005). Nearly a decade later, the reference genome sequence 
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of pigs was published in Nature (Groenen et al., 2012). In the meanwhile, the genome 
sequences of several pig breeds are available inclusive the Göttingen minipig (Groenen, 
2016). Annotations of the porcine genome are steadily growing and with the establishment of 
the “DGIL Porcine Translational Research Database” this year, swine researchers have a 
powerful, searchable database at hand (Dawson et al., 2017). It consists of currently >13,000 
gene entries with 9,165 full-length RNA transcripts and 8,099 full-length protein sequences, 
corresponding to 41.7% and 42.6% of estimated genome coverage, respectively. In addition to 
the gene sequence and homology to humans, the database provides information on available 
primer and probe sequences, antibodies and other data on analyzing the gene of interest. 
Thereby, this database facilitates basic and translational research on every level. 
 
Genome editing in vitro and in vivo 
Since the first description of the function of Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR) a decade ago (Barrangou et al., 2007), this bacterial “adaptive 
immune system” against bacteriophages came a long way and revolutionized bacterial and 
eukaryotic genome editing (Barrangou and Horvath, 2017). In 2012, the CRISPR/Cas9 
system was used the first time to edit the human genome (Cong et al., 2013; Mali et al., 
2013). Only one year later, Tan et al. used CRISPR/Cas9 to manipulate the genome of 
livestock inclusive pigs (Tan et al., 2013). In 2015, the CRISPRdirect software allowed the 
simple design of guide RNAs, which directs the CRISPR/Cas9 system to the target gene 
(Naito et al., 2015). The database of the software includes porcine gene sequences facilitating 
the use of CRISPR/Cas9 in pigs. Thereby, CRISPR/Cas makes genome editing widely 
available for the porcine research community. Currently, this technology is used for molecular 
biology analyses in vitro, e.g. to study the role of apoptosis-inducing molecule p53 in an 
infection with the Porcine circovirus type 2 (Xu et al., 2016). In vivo, the CRISPR/Cas9 was 
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used to generate CD163 knockout pigs (Burkard et al., 2017). Since CD163 is the receptor for 
PRRSV, these pigs were resistant to PRRSV, the economically most important infectious 
disease for pig production worldwide (Burkard et al., 2017). In addition, ambitious 
researchers use the CRISPR/Cas9 system to generate immune deficient pigs (Sper and 
Piedrahita, manuscript in preparation). Final goal of this project is to populate these pigs with 
human immune cells to generate humanized pigs for biomedical research 
(https://projectreporter.nih.gov/project_info_description.cfm?aid=9384776&icde=35976755). 
Thereby, the CRISPR/Cas9 system could even improve the biological relevance for studying 
human diseases inclusive STIs and holds extensive potential for the future of the porcine 
model. 
 
Characterization of the porcine immune response 
An important goal of biomedical research is to provide a comprehensive 
understanding of the immune response to infection. Therefore, the better the immunological 
toolbox to study infection and immunity in an animal model is, the more relevant is the 
model. The technology to detect pathogen-specific antibodies in enzyme-linked 
immunosorbent assay (ELISA) and neutralizing antibodies by various methods have been 
available in swine for decades and are still valuable and up-to-date tools to study the porcine 
humoral immune response (Bøje et al., 2016; Käser et al., 2017). Studying the cellular 
immune response on the other hand was rather limited for a long time in swine but the last 
decade brought some major developments. With the increased annotation coverage of the 
porcine genome, more immune targets became available for qPCR mRNA expression analysis 
(Dawson et al., 2017). The development of multiplex qPCR further optimized the system by 
facilitating high-throughput qPCR analysis, especially for limited sample volumes 
(Duvigneau et al., 2005). In addition, multiplexed cytokine and chemokine protein analysis 
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was established (Bjerre et al., 2009) and became commercially available from several 
providers, further improving the former standard cytokine and chemokine ELISAs. 
While these developments certainly improved the porcine toolbox, the main 
development was the establishment of pFCM for swine. At the beginning of the millennium, 
due to a lack of fluorochrome-conjugated antibodies detecting porcine antigens, FCM analysis 
required an indirect staining strategy limiting porcine FCM to mainly three colors (Saalmüller 
et al., 2002). Due to the increased popularity of the porcine model over the past years, the 
industry started to offer fluorochrome-antibody conjugation kits and fluorochrome-labeled 
antibodies for pigs. This development enabled the use of pFCM for pigs and facilitated a 
much more in-depth analysis of the cellular immune response. To date, pFCM has provided a 
better and more detailed understanding of the phenotype, maturation and differentiation of 
porcine innate immune cells, B cells, NK cells and T-cells (Braun et al., 2017; Summerfield et 
al., 2015a; Talker et al., 2013). In addition, pFCM improved the functional analysis of these 
cells by combining phenotypic analyses with the production of important cytokines as 
interleukin (IL-) 2, IL-4, IL-17, IFN-γ, and TNF-α (Käser et al., 2017; Talker et al., 2016). 
This improvement has major benefits for the study of infectious diseases as STIs if combined 
with a system to detect pathogen-specific immune cells. The recent developments in next-
generation MHC(SLA)-typing (Sørensen et al., 2017), neural network-based prediction of 
SLA-binding peptides (Nielsen and Andreatta, 2016; Welner et al., 2017) and recombinant 
expression of SLA class I molecules for peptide-specific staining of reactive CD8+ T-cells 
using tetramers, allow for detailed studies of cell-mediated immune responses against 
pathogens in pig models (Baratelli et al., 2017). Besides tetramer staining, pathogen-specific 
immune cells can be detected by pFCM upon in vitro restimulation of immune cells with 
pathogen antigens like peptides, proteins, whole-cell lysates, or by co-culturing of immune 
cells with infected host cells like epithelial cells. Thereby, we can determine which immune 
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cell subset is involved in an immune response against a pathogen, analyze how much and 
which immune modulators these cells produce, and into which subset of memory immune 
cells they develop. This combined analysis allows the detection of multifunctional T-cells 
(Tmulti) (Käser et al., 2017; Talker et al., 2016), and central and effector memory cells (TCM 
and TEM) (Talker et al., 2013). Tmulti-cells combine the simultaneous strong production of 
multiple cytokines with a long lifespan. They can frequent lymph nodes as well as the 
periphery, thereby integrating characteristics of TCM and TEM, respectively (Seder et al., 
2008). Due to their versatile effector function and migration potential, and their long lifespan, 
the induction of Tmulti-cells is the goal of many vaccines, and porcine pFCM enables their 
detection in pigs. 
These developments provide access to gene and protein sequence information, state-
of-the-art immunological tools for genome modification, and a comprehensive 
characterization of the immune response and the induction of immunological memory upon 
infection and vaccination in pigs. In combination with the high biological relevance, these 
developments make the pig a very valuable large animal model for studying human STIs as 
well as for other infections. 
 
CONCLUSIONS 
So far the swine model has been successful in the study of several human STIs. 
However, as presented in this review there is potential to further develop it. New technologies 
such as CRISPR/Cas9, offering convenient, fast, and reliable methods to refine animal 
models, and pFCM enabling a comprehensive analysis of the host immune response to 
infection, will most probably boost the swine model in the next decades. 
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Box 1: Advantages of pigs for STI vaccine development: 
- Availability: Important species for meat production ensures easy access to animals. Blood 
and various tissues as lymph nodes and genital tracts are byproducts and provide unlimited 
access to primary cells for in vitro analyses of infection and immunity.  
- Susceptibility to pathogens: Pigs and humans share the susceptibility to several sexually 
transmitted infection (STI) pathogens including viruses as the hepatitis E virus and bacteria as 
Chlamydia sp. (Meurens et al., 2012; Lorenzen et al., 2015b). 
- Affordable costs: Costs for a standard 3-week in vivo vaccine trial are with ~20,000 USD very 
affordable compared to non-human primates, which can be ten times more expensive. 
- Physiology: Pigs have a very similar physiology to humans including size, skin and mucosa, 
facilitating for example the determination of the optimal vaccine dosage and route of delivery 
including new methods of vaccine delivery as skin needle patches and mucosal vaccines 
(Gerdts et al., 2015; Meurens et al., 2012). 
- Reproductive cycle: Pigs and humans have similar reproductive cycles even if pig cycle has a 
shorter duration (21 days vs. 28 days). This similarity is of high importance for testing vaccine 
candidates against STIs since hormones influence host susceptibility for a pathogen and the 
immune response in the genital tract (Lorenzen et al., 2015b). 
- Immune system: The immune system of pigs is very similar to the human immune system 
facilitating the translation of results obtained on the immune response induced by a vaccine 
to humans (Meurens et al., 2012). 
- Immunological toolbox: In order to correctly evaluate safety, efficacy and to find immune 
correlates of protection it is essential to be able to detect i) pathogen burden, ii) pathological 
changes and iii) the induced immune response with a focus on immunological memory. 
Protocols for detection of pathogens in pig samples are readily available using quantitative 
PCR (qPCR). Pathological changes in pigs can be determined either by expert evaluation of 
whole organs or by histology/immunohistochemistry. While the tools for analyzing the 
porcine immune response are not as sophisticated as for mice, there have been many 
improvements during the last years. Readily available analyses of the porcine immune 
response include the antigen-specific humoral immune response via detection of 
immunoglobulin (Ig) subclasses via ELISA and neutralizing antibodies analysis (e.g. via flow 
cytometry). A detailed analysis of the cellular immune response can be performed via qPCR as 
well as multi-color flow cytometry and includes important memory T-cell subsets as 
multifunctional T-cells (T ), central memory T-cells (TCM) and effector memory T-cells (TEM) for 
an optimal analysis of the induction of immunological memory (Käser et al., 2017; Talker et 
al., 2016). 
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Table 1: Anatomical, physiological and immunological comparison of human and porcine female 
reproductive system 
 Human Pig Refs 
-Bicornual uterus No Yes (König and G, 2009) 
-Length of the uterus (cm) 7 37 (minipig) (Konar, 2014) 
-Cervical columnar epithelial cells Yes Almost absent (Eurell and Frappier, 2006; Krause, 2005) 
-Length of reproductive cycle 28 days 19-21 days (Eurell and Frappier, 2006; Senger, 2005; 
Silverthorn, 2007) 
-Endometrial sloughing (menses) Yes No (Bode et al., 2010; Senger, 2005; Swindle et al., 
2012) 
-Follicular phase hormones LH, FSH, Estrogen LH, FSH, Estrogen (Lorenzen et al., 2015b; Senger, 2005; Silverthorn, 
2007) 
-Luteal phase hormone Progesterone Progesterone (Lorenzen et al., 2015b; Senger, 2005; Silverthorn, 
2007) 
-Inducer of luteolysis Ovarian PGF2α Uterine PGF2α (“Corpus Luteum,” 2015) 
-pH in vagina 3.5-5 (acidic) ~7 (neutral) (Lorenzen et al., 2015b; Mather et al., 1977; 
Quayle, 2002) 
-High Lactobacillus % in vaginal 
flora 
Yes No (Bara et al., 1993; Farage et al., 2010; Lorenzen et 
al., 2015b)  
    
-Dominant genital Ig isotype IgG>IgA2>IgA1 IgG>IgA (no subtypes) (Butler and Brown, 1994; Cerutti, 2008; Mestecky 
et al., 2010; Snoeck et al., 2006) 
-Decreasing Ig levels around 
ovulation 
Yes Yes (Hussein et al., 1983; Kutteh et al., 1996) 
-Genital mucosal lymphoid 
aggregates 
Yes Yes (Russell and Mestecky, 2002; “The porcine cervix,” 
2015) 
-Influx of neutrophils in the 
endometrium 
With progesterone in 
luteal phase 
With estrogen in 
follicular phase 
(Booker et al., 1994; Hussein et al., 1983; 
Jiwakanon et al., 2005; Kaeoket et al., 2002) 
LH: Luteinizing hormone; FSH: Follicle stimulating hormone; PGF: Prostaglandin 
 
Table 2: Anatomical comparison of human and porcine male reproductive system 
 Human Pig Refs 
-Preputial diverticulum No Yes (Eurell and Frappier, 2006; König and G, 
2009; Krause, 2005; Lossi et al., 2016; 
Silverthorn, 2007; Swindle et al., 2012; 
Wrobel and Bergman, 2006) 
-Sigmoid flexure No Yes 
-Penis/prepuce epithelium Squamous Squamous  
-Significant erectile tissue Yes No  
-Urethral epithelium Pseudostratified columnar Transitional  
-Ampulla of ductus deferens Present Absent  
 
Figure legends 
Figure 1: Gross anatomy of the porcine female genital tract  
The long vagina (V) is followed by the cervix (C), the length of which is indicated by a bar. 
The urinary bladder (U) is closely associated with the vagina. The cervix, the uterine corpus 
(UC) and segments of the uterine horns (UH) have been opened exposing an edematous 
mucosa (M). Notice the short uterine body that continues into two long uterine horns. The 
coiled Fallopian tubes (FT) can be seen extending from the tip of the uterine horns towards 
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the ovaries and the ovarian bursa (B). The ovaries have been sectioned revealing multiple 
corpora lutea, which are easily assessed in the left ovary (LO). Bar = 5 cm. Ten-month-old 
Göttingen minipig. 
 
Figure 2: Gross anatomy of the porcine male genital tract 
The preputial skin (PS) has been sectioned exposing the left preputial diverticle (PD) and the 
preputial mucosa (PR) that envelopes the free part of the penis (PE). Urine is oozing from the 
opened preputial diverticle (asterix). The length and location of the sigmoid flexure (SF) of 
the penis is indicated by a bar. The penis continues caudally into the bulb of the penis (BP) 
and is no longer visible as it continues under the accessory genital glands. In the male pig, 
these glands are dominated by the large bilateral, almost symmetrical bulbourethral glands (B) 
and the vesicular gland (V). The prostate gland (P) is relatively small and only a portion can 
be seen between the lobes of the vesicular gland. The vesicular gland is closely associated to 
the urinary bladder (U). The spermatic cord has been opened exposing the ductus deferens 
(DD). The vaginal tunice of the right testis (RT) has been opened exposing the surface of the 
testis, the head (HE) and tail (TE) of the epididymis, while the tunice of the left testis (LT) is 
intact. Bar = 5 cm. Nine-month-old Göttingen minipig. 
 
Figure 3: Chlamydia trachomatis - animal models, pros and cons 
Chlamydia: C.; Lower Genital Tract: LGT; Major Outer Membrane Protein: MOMP; 
Interferon gamma: IFN-γ; Sexually Transmitted Infection: STI 
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Fig. 2 
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Fig. 3 
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Highlights 
-Pigs are being used as preclinical animal models for various human infections. 
-The pig can be used for the study of male and female human sexually transmitted infections. 
-They make surrogate or natural animal models to decipher Chlamydia trachomatis pathogenesis 
-Human medical research needs alternative animal models that are more predictive. 
-New technologies such as CRISPR-Cas9 open the doors to new exciting developments of the model. 
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